BNP PARIBAS FINANCIAL MARKETS - DIPLOMAT PHARMACY INC ownership

DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 141 filers reported holding DIPLOMAT PHARMACY INC in Q4 2019. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of DIPLOMAT PHARMACY INC
ValueSharesWeighting
Q4 2019$88,624,000
+73.8%
22,156
+112.9%
0.00%
Q3 2019$50,984,000
-24.9%
10,405
-6.7%
0.00%
Q2 2019$67,904,000
-10.8%
11,150
-14.9%
0.00%
Q1 2019$76,134,000
+136.1%
13,104
+446.9%
0.00%
Q4 2018$32,250,000
-48.8%
2,396
-26.1%
0.00%
Q3 2018$62,966,000
-66.2%
3,244
-55.4%
0.00%
Q2 2018$186,102,000
-69.9%
7,281
-76.3%
0.00%
-100.0%
Q1 2018$618,665,000
+26.5%
30,703
+26.0%
0.00%0.0%
Q4 2017$489,126,000
-5.1%
24,371
-2.0%
0.00%0.0%
Q3 2017$515,286,000
+148.8%
24,881
+77.8%
0.00%0.0%
Q2 2017$207,082,000
+46.3%
13,992
+57.6%
0.00%
Q1 2017$141,572,000
+44.0%
8,876
+13.8%
0.00%
Q4 2016$98,318,000
-48.4%
7,803
+14.8%
0.00%
-100.0%
Q3 2016$190,412,000
-53.5%
6,798
-41.9%
0.00%
-50.0%
Q2 2016$409,570,000
+192.0%
11,702
+128.6%
0.00%
+100.0%
Q1 2016$140,261,000
-41.0%
5,119
-26.3%
0.00%0.0%
Q4 2015$237,692,000
+10.7%
6,946
-7.0%
0.00%0.0%
Q3 2015$214,642,000
+59.4%
7,471
+148.2%
0.00%
Q2 2015$134,698,000
+961.4%
3,010
+720.2%
0.00%
Q1 2015$12,691,0003670.00%
Other shareholders
DIPLOMAT PHARMACY INC shareholders Q4 2019
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 445,200$7,101,0001.80%
Redmile Group, LLC 1,254,342$20,007,0001.30%
Irving Magee Investment Management 166,505$2,656,0001.02%
BROADVIEW ADVISORS LLC 376,050$5,998,0000.83%
Sivik Global Healthcare LLC 101,000$1,611,0000.75%
FRONTIER CAPITAL MANAGEMENT CO LLC 5,455,461$87,015,0000.64%
Iguana Healthcare Management, LLC 75,000$1,196,0000.59%
RIVERBRIDGE PARTNERS LLC 1,464,286$23,355,0000.47%
HERMES INVESTMENT MANAGEMENT LTD 1,772,777$28,276,0000.46%
Endurant Capital Management LP 85,043$1,356,0000.44%
View complete list of DIPLOMAT PHARMACY INC shareholders